TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CALCIUM ACETATE

CALCIUM ACETATE
Approved 2008-01-30
14
Indications
--
Phase 3 Trials
18
Years on Market

CALCIUM ACETATE Approval History

Loading approval history...

What CALCIUM ACETATE Treats

14 FDA approvals

Originally approved for its first indication in 2008 . Covers 14 distinct patient populations.

  • Other (14)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CALCIUM ACETATE FDA Label Details

Pro

Indications & Usage

Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). Calcium acetate is a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.